Cite
MLA Citation
A. Vogel et al.. “618OHealth-related quality of Life (HRQOL) and disease symptoms in patients with unresectable hepatocellular carcinoma (HCC) treated with lenvatinib (LEN) or sorafenib (SOR).” Annals of oncology, vol. 28, n.d., p. . http://access.bl.uk/ark:/81055/vdc_100097081410.0x000023